Viatris VTRS
NASDAQ VTRS
$16.50 -0.11 (-0.69%)
As of: Sep 9, 2026 · 2:33 PM EDT

Viatris (VTRS) Prepaid Assets (2019 - 2026)

Viatris (VTRS) posted Prepaid Assets of $2.1 billion for Q2 2026, little changed on a QoQ basis from $2.1 billion in Q1 2026, and up 25.15% year-over-year from $1.7 billion in Q2 2025.

Analysis

Viatris (VTRS) Prepaid Assets (2019 - 2026) Analysis & Trends

Viatris has reported Prepaid Assets for 8 years, with the latest figure at $2.1 billion in Q2 2026.

  • On a quarterly basis, Prepaid Assets rose 25.15% year-over-year to $2.1 billion in Q2 2026; TTM through Jun 2026 was $2.1 billion, a 25.15% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, down 16.03% from the prior year.
  • Prepaid Assets was $2.1 billion for Q2 2026 at Viatris, roughly flat from $2.1 billion in the prior quarter.
  • The five-year high for Prepaid Assets was $2.1 billion in Q2 2026, with the low at $1.4 billion in Q4 2025.
  • Average Prepaid Assets over 5 years is $1.8 billion, with a median of $1.7 billion recorded in 2023.
  • The sharpest annual moves came in 2022 and 2026: Prepaid Assets decreased 19.96% in 2022, then rose 28.2% in 2026.
  • Over 5 years, Prepaid Assets stood at $1.8 billion in 2022, then grew by 11.98% to $2.0 billion in 2023, then retreated by 15.66% to $1.7 billion in 2024, then slipped by 16.03% to $1.4 billion in 2025, then soared by 46.89% to $2.1 billion in 2026.
  • The last three Prepaid Assets figures came in at $2.1 billion (Q2 2026), $2.1 billion (Q1 2026), and $1.4 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.63 Bn 38.97 Bn 2.15 Bn
2 Viatris 19.19 Bn 18.30 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.48 Bn 5.35 Bn 334.51 Mn
5 Bausch Health Companies 2.36 Bn 520.30 Mn 2.10 Bn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn
8 Amphastar Pharmaceuticals 995.52 Mn 705.40 Mn 93.47 Mn
9 Fennec Pharmaceuticals 404.35 Mn 363.10 Mn 17.15 Mn
10 RedHill Biopharma 176.59 Mn 176.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.11 Bn
Mar 31, 2026 2.11 Bn
Dec 31, 2025 1.44 Bn
Sep 30, 2025 1.49 Bn
Jun 30, 2025 1.69 Bn
Mar 31, 2025 1.65 Bn
Dec 31, 2024 1.71 Bn
Sep 30, 2024 1.63 Bn
Jun 30, 2024 1.76 Bn
Mar 31, 2024 1.93 Bn
Dec 31, 2023 2.03 Bn
Sep 30, 2023 1.78 Bn
Jun 30, 2023 1.73 Bn
Mar 31, 2023 1.76 Bn
Dec 31, 2022 1.81 Bn
Sep 30, 2022 1.70 Bn
Jun 30, 2022 1.70 Bn
Mar 31, 2022 1.76 Bn
Dec 31, 2021 1.96 Bn
Sep 30, 2021 2.12 Bn